Accounts Receivable

12 Months Ended

Dec. 31, 2012

Accounts Receivable [Abstract]

Accounts Receivable

4. Accounts Receivable

Our accounts receivable represent amounts due to Progenics from collaborators, royalties, research grants and the sales of research reagents. These amounts are considered to be short-term as they are expected to be collected within one year and we believe carrying value approximates fair value. Accounts receivable as of December 31, 2012 and 2011, consisted of the following:

	2012		2011
Collaborators	$	6,125	$	77
Royalties		781		1,279
Research grants		12		100
Other		19		60
Total	$	6,937	$	1,516